Enhancing Pharmacovigilance Intake Processes With AI And Automation

Discover how AI and automation can transform pharmacovigilance in this insightful webinar.

This webinar session will explore the evolution of the ARTEMIS (Adverse Event Processing using Technology Enabled Medical and Intelligent Solution) project launched by PSPV and Sanofi Digital 6 years ago with a previous partner which was achieving significant benefits through NLP and Artificial Intelligence. Then due to unforeseen constraints Sanofi started working with IQVIA to move to a new system within 6 months and continue the journey of optimization and improvement.

This partnership showcases how organizations can stay adaptable, even through shifting circumstances, to sustain momentum in digital safety innovation.

Key Takeaways:

Efficiency Gains: Learn how AI can streamline intake processes, reducing the time and effort required for data handling.
Collaborative Innovation: Gain insights into how Sanofi and IQVIA maintained progress and adapted in response to evolving needs in patient safety.
Actionable Insights: Gain practical ideas on adapting and adopting similar strategies to improve your pharmacovigilance operations.

Register for the Webinar

Your company email address

Please select your industry: (max 1)
Ask a question early:
Yes, I would like to be contacted by an IQVIA expert

Opt In?

Berne Media may store and process my information. For details, see the Privacy Notice.
Citeline (previously Pharma Intelligence UK) may contact me with updates, relevant promotions and information about products. My Information will be used in accordance with the Citeline Privacy Policy, and you withdraw your permission to receive any of our communications at any time.
By clicking submit, you consent to allow IQVIA to store and process the information submitted to provide you the content requested. They are subject to IQVIA Terms and Conditions.

Please complete all required fields to access the content!

Securing your samples: Strategies for safeguarding critical biological materials

To deliver these therapies to the patients who need them, their success hinges on effective storage and management to maintain integrity throughout their lifecycle. From early development to commercialization, safeguarding sensitive biological materials demands scalable storage solutions and meticulous risk mitigation strategies. Partnering with a CDMO specializing in ultracold storage and biorepository management is critical to preserving product integrity and ensuring continuity throughout every development stage. This webinar will explore how the right CDMO partner can streamline biological material storage, mitigate risks, and provide the scalability needed to support growth from clinical trials to commercial launch, empowering you to advance your pipeline with confidence. Participants will gain insight into:

A New Era of Participant Payment Services

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering:

From biomarkers to regulatory compliance, and the impact of AI/ML

The field of precision medicine is rapidly evolving, enabling the development of innovative therapies highly tailored to individuals’ genetic profiles - resulting in revolutionized treatments and improved patient outcomes. Discover expert insights on the current landscape of personalized medicine, including the opportunities and challenges, including: